Melanoma complicating treatment with natalizumab (tysabri) for multiple sclerosis.
Ismail
Azza
A
Kemp
Julie
J
Sharrack
Basil
B
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D008545:Melanoma / Q000139:chemically induced* / Q000601:surgery; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy; D000069442:Natalizumab; D016032:Randomized Controlled Trials as Topic; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000601:surgery; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab